Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation.

@article{Ahmad2015CarbonMI,
  title={Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation.},
  author={Shakil Ahmad and Peter William Hewett and Takeshi Fujisawa and Samir Sissaoui and Meng Cai and Geraldine Gueron and Bahjat Al‐Ani and Melissa J. Cudmore and S Faraz Ahmed and Michael K. K. Wong and Barbara Wegiel and Leo E. Otterbein and Libor V{\'i}tek and Wenda Ramma and Keqing Wang and Asif Ahmed},
  journal={Thrombosis and haemostasis},
  year={2015},
  volume={113 2},
  pages={
          329-37
        }
}
Carbon monoxide (CO) is a gaseous autacoid known to positively regulate vascular tone; however, its role in angiogenesis is unknown. The aim of this study was to investigate the effect of CO on angiogenesis and vascular endothelial growth factor (VEGF) receptor-2 phosphorylation. Human umbilical vein endothelial cells (HUVECs) were cultured on growth factor-reduced Matrigel and treated with a CO-releasing molecule (CORM-2) or exposed to CO gas (250 ppm). Here, we report the surprising finding… 

Figures from this paper

Identification of cyclins A1, E1 and vimentin as downstream targets of heme oxygenase-1 in vascular endothelial growth factor-mediated angiogenesis

Vimentin and cyclins A1 and E1 represent VEGF-activated HO-1-dependent targets important for VEGf-driven angiogenesis, and structural protein vimentin as an additional V EGF-HO-1 target is identified.

Carbon monoxide in lung cell physiology and disease.

CO, through modulation of signaling pathways, can impact key biological processes including autophagy, mitochondrial biogenesis, programmed cell death (apoptosis), cellular proliferation, inflammation, and innate immune responses.

Repurposing old carbon monoxide-releasing molecules towards the anti-angiogenic therapy of triple-negative breast cancer

It is proposed that CORM-2 may be pursued further as an additional agent in combination with existing anti-angiogenic therapies for a more successful targeting of malignant angiogenesis in TNBC.

Carbon Monoxide Releasing Molecule-A1 (CORM-A1) Improves Neurogenesis: Increase of Neuronal Differentiation Yield by Preventing Cell Death

CO appears as a promising therapeutic molecule to stimulate endogenous neurogenesis or to improve in vitro neuronal production for cell therapy strategies as well as a novel biological role disclosed herein.

Carbon Monoxide modulation of neuronal differentiation

CO appears as a promising therapeutic molecule to stimulate endogenous neurogenesis or to improve in vitro neuronal production for cell therapy strategies and prevents cell death during neuronal differentiation.

Canagliflozin Inhibits Human Endothelial Cell Inflammation through the Induction of Heme Oxygenase-1

It was found that HO-1-derived bilirubin contributed to the anti-inflammatory action of canagliflozin, but not theAnti-proliferative and antimigratory effects of the drug.

Combining carbon monoxide-releasing molecules with anti-VEGF therapy for triple-negative breast cancer therapy

Two of the commercially available and two of the newly synthesized CORMs showed promising anti-angiogenic properties and should be pursued further, in order to identify a mechanism of action for these organometallic complexes.

Syddansk Universitet Carbon Monoxide Releasing Molecule-A 1 ( CORM-A 1 ) Improves Neurogenesis Increase of Neuronal Differentiation Yield by Preventing Cell

In the case of SH-S5Y5 model, small amounts of reactive oxygen species (ROS) generation emerges as important signaling molecules during CO-promoted neuronal differentiation, and ROS signaling emerged as key factors in CO’s increasing number of differentiated neurons in OHSC.

Role of epithelial Na+ channels in endothelial function

The data suggest that ENaCs that are endogenous to human endothelial cells are mechano-sensitive, which could inevitably lead to endothelium dysfunction and even vascular diseases such as atherosclerosis.

References

SHOWING 1-10 OF 51 REFERENCES

Carbon monoxide signaling in promoting angiogenesis in human microvessel endothelial cells.

Data suggest that HO-mediated angiogenesis and cell proliferation were dependent on HO-1- and not HO-2-derived CO, and not tricarbonylchloro(glycinato) ruthenium(II) (CORM-3), which was a potent enhancer ofAngiogenesis.

Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells.

The data indicate that HO-1 activity influences the generation of VEGF in VSMC in both normoxic and hypoxic conditions, and indicates that CO and iron, respectively the inducer and the inhibitor of V EGF synthesis, are concomitantly produced during the degradation of heme.

Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration.

It is proposed that during chronic inflammation HO-1 has 2 roles: first, an anti-inflammatory action inhibiting leukocyte infiltration; and second, promotion of VEGF-driven noninflammatory angiogenesis that facilitates tissue repair.

Direct Evidence for Endothelial Vascular Endothelial Growth Factor Receptor-1 Function in Nitric Oxide–Mediated Angiogenesis

The identification Tyr794 of VEGfr-1 as a key residue in this process provides direct evidence of endothelial VEGFR-1 in NO-driven in vitro angiogenesis and highlights new therapeutic targets for management of vascular diseases.

Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis.

An overview of the role of heme oxygenase-1 and carbon monoxide in angiogenesis is provided and well-recognized antiinflammatory, antioxidant, and antiapoptotic effects are identified.

Stromal cell–derived factor 1 promotes angiogenesis via a heme oxygenase 1–dependent mechanism

A mechanistic role for heme oxygenase 1 (HO-1) in SDF-1–mediated angiogenesis is demonstrated and new avenues for therapeutic approaches in vascular repair are provided.

Protective roles of endogenous carbon monoxide in neointimal development elicited by arterial injury.

The data suggest that endogenous CO serves as a protective factor that limits the excessive VSMC proliferation associated with vascular diseases.

Negative Regulation of Soluble Flt-1 and Soluble Endoglin Release by Heme Oxygenase-1

It is demonstrated that the HO-1/CO pathway inhibits sFlt-1 and sEng release, providing compelling evidence for a protective role ofHO-1 in pregnancy, and identifies HO- 1 as a novel target for the treatment of preeclampsia.

Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide.

Results indicate that vascular SMCs have both constitutive and inducible HO activity, and they respond to specific stimuli to generate guanylyl cyclase-stimulatory CO in the same SMCs and in coincubated platelets.
...